Trials / Recruiting
RecruitingNCT06172283
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
A Pilot, Feasibility Study of Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- State University of New York at Buffalo · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a a pilot study to assess the feasibility of intermittent caloric restriction (plus a plant-enriched diet optionally) in prostate cancer patients receiving androgen deprivation therapy. Study feasibility measures will include enrollment rate, drop-out rate and compliance with diet measured by self-reports.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Intermittent Fasting | Dietary intervention |
Timeline
- Start date
- 2023-12-05
- Primary completion
- 2027-01-01
- Completion
- 2028-12-31
- First posted
- 2023-12-15
- Last updated
- 2025-02-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06172283. Inclusion in this directory is not an endorsement.